The effects of methylenecyclopropylglycine (MCPG), the lower homologue of hypoglycin A, on starved rats are described. Upon oral ingestion of MCPG (43 mg/kg), a 50 decrease in blood glucose compared with controls was observed after 4 h. The plasma concentrations of lactate and non-esterified fatty acids were substantially increased during this period. The activity of general acyl-CoA dehydrogenase from isolated rat liver mitochondria was not significantly changed. By contrast, the activity of 2-methyl-(branched-chain)-acyl-CoA dehydrogenase decreased by over 80 The enzyme activity of enoyl-CoA hydratase (crotonase) from pig kidneys decreased by 800% on incubation with the hypothetically toxic metabolite of MCPG, methylenecyclopropylformyl-CoA. These results suggest that the inhibition spectrum of MCPG is quite different from that of hypoglycin A and that similar physiological effects might result from inhibition of different enzymes of fl-oxidation, e.g. hypoglycaemia and lacticacidemia. Accumulation of medium-chain acyl-CoA thioesters is probably at the origin of disturbances in pyruvate metabolism.
INTRODUCTION
Methylenecyclopropylglycine (MCPG) was first isolated in 1962 by Gray & Fowden [1] from the kernels of litchi fruit. It is the lower homologue of the better known hypoglycin A, with which it shares the methylenecyclopropyl function: Hypoglycin A induces a strong hypoglycaemia in mammals [2] [3] [4] [5] . The mechanism of this effect has been elucidated in some detail, the salient point being an irreversible inhibition of fl-oxidation which, in turn, results from a covalent and irreversible reaction of methylenecyclopropylacetyl-CoA (MCPA-CoA) with the flavin of general acyl-CoA dehydrogenase (GAD, EC 1.3.99.3) [6] [7] [8] [9] [10] [11] [12] [13] . MCPA-CoA is formed by degradation of hypoglycin A through a-oxidation and subsequent oxidative decarboxylation and conjugation to CoA by the branched-chain oxo-acid dehydrogenase [14] . MCPA-CoA derived from hypoglycin A is therefore the toxic metabolite (mainly) responsible for the observed effects.
Gray & Fowden reported that MCPG has a comparable hypoglycaemic effect on mice [1] . This observation has never been followed up. Recently, we succeeded with the chemical synthesis of MCPG [15] and were also able to obtain sufficient quantities of natural MCPG to study the molecular mechanism of hypoglycaemia induced by MCPG.
MATERIALS AND METHODS
Acyl-CoA thioesters and enoyl-CoA hydratase (crotonase, EC 4.2.1.17) from bovine liver were from Sigma. Crotonyl-CoA was obtained from P-L Biochemicals. 3H20 (sp. radioactivity 5 [17] , and GAD from pig kidneys by the method of Lau et al. [18] . MCPA-CoA was synthesized as described by Wenz and co-workers [12] , and methylenecyclopropylformyl-CoA (MCPF-CoA) by the method of Boschert [15] .
MCPG was isolated and purified as described elsewhere [15] It was assumed that they would not affect the results of the experiments in the concentrations used.
Animals
Male rats of the Sprague-Dawley strain (strain 50; Ivanovas, Kisslegg, Germany), weighing 160-200 g were starved for 24 h and then given MCPG orally (0-100 mg/kg). For determination of plasma parameters, blood was taken from the retro-orbital venous plexus after 0, 2 and 4 h. The animals were killed by decapitation, the livers removed and the mitochondria obtained by published procedures [19] ; 12 animals each were used for the doses 0-40 mg/kg, and six animals each for the doses 50 and 100 mg/kg.
Standard methods
Plasma glucose concentrations were determined by the hexokinase/glucose-6-phosphate dehydrogenase method [20] , and lactate concentration was measured with lactate dehydrogenase [20] . Non-esterified fatty acids (NEFA) were extracted from thc serum as Cu2" salts by using chloroform, the concentration being determined spectrophotometrically as the diethyldithiocarbamate complex [21] . For statistical comparisons, Student's t test was used.
Preparation of J2,3-3Hjacyl-CoA thioester Tritiated iso-and n-butyryl-CoA were prepared from the unlabelled analogues by using bacterial butyryl-CoA dehydrogenase from Megasphera elsdenii. Tritiated octanoyl-CoA was prepared by using GAD from pig kidney by the method described elsewhere [22] , with the following modifications. The reaction was stopped by addition of sodium deoxycholate (final concn. 0.05 00, w/v) at 0°C, the reaction mixture was applied to a Dowex lX8 column (20-50 mesh; bed volume 1 ml) and the CoA esters were eluted with approx. 1. The results summarized in Fig. 1 show that the activity of the major enzyme of fl-oxidation, medium-chain acyl-CoA dehydrogenase (GAD), remains essentially unchanged. This is consistent with studies carried out with homogeneous GAD from pig kidney [15] . The latter [12] , no chemical reaction ensues over a period of 2-3 h. This was deduced from the lack of alteration in the flavin chromophore, which normally indicates reduction, and from the activity profile, which did not change significantly. This also contrasts with 2-(methyl)-branched-chain-acyl-CoA dehydrogenase, the activity of which is decreased to 200 of its initial value.
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DISCUSSION
The effects of MCPG on the rat are indeed comparable with those observed upon administration of hypoglycin A, in that they induce a dose-and time-dependent decrease in plasma glucose (Table 1 ) [5] . This essentially confirms observations made by Gray & Fowden [1] with mice. In addition, a marked increase in plasma concentrations of lactate and NEFA is observed. The ED50 value for the decrease in the blood glucose concentration is 43 mg/kg.
These observations coincide with the assumption that, by analogy with hypoglycin A, MCPG is degraded to a toxic metabolite which directly inhibits f8-oxidation, and indirectly gluconeogenesis, possibly by inhibition of pyruvate carboxylase (a key enzyme of gluconeogenesis), by medium-chain acyl-CoA thioesters which accumulate in the mitochondrial matrix when fl-oxidation is inhibited [14] . According to Randle et al. [25] , the inhibition of fkoxidation contributes to the decrease in blood glucose by activating peripheral glucose oxidation. The decrease in plasma glucose can hardly be explained by an inhibition of GAD or (straight-chain) butyryl-CoA dehydrogenase. They are affected only marginally, if at all.
Inhibition of 2-(methyl)-branched-chain-acyl-CoA dehydrogenase, which is normally implicated in the degradation of valine or isoleucine at the site of the respective CoA alkyloxiranecarboxylic acids, which do not lead to an increase in plasma lactate [26, 27] . This appears to suggest that the toxic intermediate of MCPG leads to inhibition of oxidative decarboxylation (e.g. pyruvate dehydrogenase) and/or the citrate cycle.
The most striking phenomenon is the difference in inhibition properties on general acyl-CoA dehydrogenase induced by hypoglycin A or MCPG.
